Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Early reduction of skin potassium without sodium accumulation in the pathogenesis of salt sensitivity in primary aldosteronism

P. Mlejnek, F. Liška, J. Šilhavý, K. Večerková, M. Šimáková, M. Pravenec, TW. Kurtz

. 2025 ; 16 (-) : 1575972. [pub] 20250429

Status neindexováno Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25014460

INTRODUCTION: Primary aldosteronism is the most common form of secondary hypertension and blood pressure salt sensitivity. In the setting of hyperaldosteronism and a high-salt diet, disturbances in tissue sodium and potassium levels may contribute to salt sensitivity. This study aimed to determine whether aldosterone-dependent changes in tissue and plasma sodium and potassium concentrations occur before or after the development of salt sensitivity and hypertension in a rat model of primary aldosteronism. Previous studies in this model show that aldosterone-dependent salt sensitivity develops after 7-10 days on a high-salt diet. A secondary objective was to investigate differences in skin gene expression between aldosterone-treated rats and vehicle-treated controls. METHODS: Unilaterally nephrectomized male Sprague-Dawley rats received continuous infusions of aldosterone or vehicle while being fed a high-salt diet. Electrolyte concentrations in plasma, carcass, and skin were measured after 2 and 14 days of high-salt feeding. Tissue sodium and potassium concentrations were determined by atomic absorption spectroscopy and expressed as mmol/g tissue dry weight, while plasma ions (mmol/L) were measured using ion-selective electrodes. RNA sequencing (RNAseq) was used to identify differentially expressed genes in the skin, and gene set enrichment analysis (GSEA) was performed to explore biological processes associated with aldosterone treatment. RESULTS: After 2 days on the high-salt diet, aldosterone-treated rats showed significantly lower skin and plasma potassium concentrations compared to vehicle-treated controls, while sodium concentrations in the carcass, skin, and plasma did not differ significantly. At 14 days, aldosterone-treated rats continued to exhibit lower plasma potassium levels, although skin potassium differences were no longer significant. Carcass sodium concentrations were significantly higher in aldosterone-treated rats at 14 days. GSEA revealed that, at 2 days, aldosterone treatment affected biological processes related to electrolyte homeostasis and hyperosmotic responses. At 14 days, biological processes related to muscle function and calcium ion transport were significantly altered. CONCLUSION: Aldosterone-treated rats on a high-salt diet for 2 days had lower skin and plasma potassium levels compared to salt-loaded controls, suggesting early potassium depletion precedes significant sodium accumulation and blood pressure increases. These findings raise the possibility that early potassium depletion contributes to the development of aldosterone-induced salt sensitivity. Further studies with detailed time-course analysis will be of interest to elucidate the role of early potassium depletion in increasing vascular resistance and triggering aldosterone-dependent salt sensitivity and hypertension.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25014460
003      
CZ-PrNML
005      
20250905141326.0
007      
ta
008      
250701e20250429sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fphar.2025.1575972 $2 doi
035    __
$a (PubMed)40365307
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Mlejnek, Petr $u Institute of Physiology, Czech Academy of Sciences, Prague, Czechia
245    10
$a Early reduction of skin potassium without sodium accumulation in the pathogenesis of salt sensitivity in primary aldosteronism / $c P. Mlejnek, F. Liška, J. Šilhavý, K. Večerková, M. Šimáková, M. Pravenec, TW. Kurtz
520    9_
$a INTRODUCTION: Primary aldosteronism is the most common form of secondary hypertension and blood pressure salt sensitivity. In the setting of hyperaldosteronism and a high-salt diet, disturbances in tissue sodium and potassium levels may contribute to salt sensitivity. This study aimed to determine whether aldosterone-dependent changes in tissue and plasma sodium and potassium concentrations occur before or after the development of salt sensitivity and hypertension in a rat model of primary aldosteronism. Previous studies in this model show that aldosterone-dependent salt sensitivity develops after 7-10 days on a high-salt diet. A secondary objective was to investigate differences in skin gene expression between aldosterone-treated rats and vehicle-treated controls. METHODS: Unilaterally nephrectomized male Sprague-Dawley rats received continuous infusions of aldosterone or vehicle while being fed a high-salt diet. Electrolyte concentrations in plasma, carcass, and skin were measured after 2 and 14 days of high-salt feeding. Tissue sodium and potassium concentrations were determined by atomic absorption spectroscopy and expressed as mmol/g tissue dry weight, while plasma ions (mmol/L) were measured using ion-selective electrodes. RNA sequencing (RNAseq) was used to identify differentially expressed genes in the skin, and gene set enrichment analysis (GSEA) was performed to explore biological processes associated with aldosterone treatment. RESULTS: After 2 days on the high-salt diet, aldosterone-treated rats showed significantly lower skin and plasma potassium concentrations compared to vehicle-treated controls, while sodium concentrations in the carcass, skin, and plasma did not differ significantly. At 14 days, aldosterone-treated rats continued to exhibit lower plasma potassium levels, although skin potassium differences were no longer significant. Carcass sodium concentrations were significantly higher in aldosterone-treated rats at 14 days. GSEA revealed that, at 2 days, aldosterone treatment affected biological processes related to electrolyte homeostasis and hyperosmotic responses. At 14 days, biological processes related to muscle function and calcium ion transport were significantly altered. CONCLUSION: Aldosterone-treated rats on a high-salt diet for 2 days had lower skin and plasma potassium levels compared to salt-loaded controls, suggesting early potassium depletion precedes significant sodium accumulation and blood pressure increases. These findings raise the possibility that early potassium depletion contributes to the development of aldosterone-induced salt sensitivity. Further studies with detailed time-course analysis will be of interest to elucidate the role of early potassium depletion in increasing vascular resistance and triggering aldosterone-dependent salt sensitivity and hypertension.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Liška, František $u Institute of Physiology, Czech Academy of Sciences, Prague, Czechia $u Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czechia
700    1_
$a Šilhavý, Jan $u Institute of Physiology, Czech Academy of Sciences, Prague, Czechia
700    1_
$a Večerková, Kateřina $u Laboratory of Genomics and Bioinformatics, Institute of Molecular Genetics, Czech Academy of Sciences, Prague, Czechia $u Department of Informatics and Chemistry, University of Chemistry and Technology, Prague, Czechia
700    1_
$a Šimáková, Miroslava $u Institute of Physiology, Czech Academy of Sciences, Prague, Czechia
700    1_
$a Pravenec, Michal $u Institute of Physiology, Czech Academy of Sciences, Prague, Czechia $u Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czechia
700    1_
$a Kurtz, Theodore W $u Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, United States
773    0_
$w MED00174597 $t Frontiers in pharmacology $x 1663-9812 $g Roč. 16 (20250429), s. 1575972
856    41
$u https://pubmed.ncbi.nlm.nih.gov/40365307 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250701 $b ABA008
991    __
$a 20250905141314 $b ABA008
999    __
$a ok $b bmc $g 2388092 $s 1251580
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2025 $b 16 $c - $d 1575972 $e 20250429 $i 1663-9812 $m Frontiers in pharmacology $n Front Pharmacol $x MED00174597
LZP    __
$a Pubmed-20250701

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...